STAT+: Pharmalittle: We’re reading about a setback for Argenx, Lilly suits over copycat versions of an obesity drug, and more

Written and edited by the WorldPing NewsdeskPublished Updated Original reporting: STAT
STAT+: Pharmalittle: We’re reading about a setback for Argenx, Lilly suits over copycat versions of an obesity drug, and moreWorldPing
Image via STAT.

What happened

The FDA flagged a potential safety signal after four patient deaths in a trial testing a schizophrenia drug, Argenx faces an unusual setback, and more pharma news.

Key facts

  • Reported by STAT and published Fri, 09 Oct 2026 13:17:20 UTC.

Why it matters

Outbreaks, approvals and guidance changes have direct practical consequences for care, travel and public-health planning.

What to watch next

  • Case numbers and official guidance updates
  • Regulatory decisions in other countries
  • Supply, recall or access changes

Sources

The original report was published by STAT. WorldPing does not claim that reporting — this page summarises and contextualises it.

Read the full report at STAT

Related WorldPing coverage

Lawsuits blame Fox News for deaths of journalists in UkraineWorldPing
France 24

Lawsuits blame Fox News for deaths of journalists in Ukraine

This week, FRANCE 24's media show Scoop revisits a fatal assignment for a Fox News team in Ukraine. On March 14, 2022, a Russian strike hit the crew reporting near the capital Kyiv.

Brief by WorldPing · Original reporting by France 24